The Latest Breaking News from da Vinci

Intuitive Surgical is set to announce its first-quarter results this month, with analysts forecasting double-digit growth in its bottom-line figure.

This robotic AI stock is a “buy and hold” stock for the long term despite its lofty valuation.

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

Intuitive Surgical has substantially outperformed the Dow over the past year, and analysts remain moderately bullish on the stock’s prospects.

The same kind of AI that powers OpenAI's ChatGPT is enabling more autonomous surgical robots—and that should be good news for patients and surgeons alike.

AI could soon transform the medical technology industry, and this market leader may continue to dominate.

Intuitive Surgical is a healthcare giant that has delivered market-crushing returns to long-term shareholders. Is ISRG stock still a good buy?

With robots making waves across industries from healthcare to manufacturing, now might be the perfect time to invest in leading players such as Intuitive Surgical (ISRG), Fanuc Corp. (FANUY), and iRobot Corp. (IRBT) to garner solid returns. Read on….

AI is rapidly transforming the healthcare industry. Evolving companies such as Intuitive Surgical and Recursion Pharmaceuticals can capitalize on this opportunity.

Intuitive Surgical is expected to report its second-quarter earnings this month, and Wall Street analysts expect a marginal profit decline.

Robots and AI are revolutionizing industries by automating routine tasks, freeing us for more meaningful work. Hence, investors eyeing AI and robotics could consider investing in Intuitive Surgical (ISRG), Rockwell Automation (ROK), and Teradyne (TER), which stands at the forefront of innovation. Read on….